Dr. Kris Describes the Genetic Mutation Screening Study

Mark G. Kris, MD
Published: Thursday, Jun 30, 2011



Mark G. Kris, MD, chief of the Thoracic Oncology Service at Memorial Sloan-Kettering Cancer Center, describes the genetic mutation screening multicenter study that he was the lead author for and presented at the 2011 annual meeting of the American Society of Clinical Oncology.


Mark G. Kris, MD, chief of the Thoracic Oncology Service at Memorial Sloan-Kettering Cancer Center, describes the genetic mutation screening multicenter study that he was the lead author for and presented at the 2011 annual meeting of the American Society of Clinical Oncology.

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Oncology Briefings™: Updates in Novel Therapeutic Options for Lung Neuroendocrine TumorsMay 31, 20181.0
Community Practice Connections™: Working Group to Optimize Outcomes in EGFR-mutated Lung Cancers: Evolving Concepts for Nurses to Facilitate and Improve Patient CareJun 30, 20181.5
Publication Bottom Border
Border Publication
x